CN102085369B - 一种口腔干燥症凝胶医疗用品及其制备方法 - Google Patents
一种口腔干燥症凝胶医疗用品及其制备方法 Download PDFInfo
- Publication number
- CN102085369B CN102085369B CN2011100312546A CN201110031254A CN102085369B CN 102085369 B CN102085369 B CN 102085369B CN 2011100312546 A CN2011100312546 A CN 2011100312546A CN 201110031254 A CN201110031254 A CN 201110031254A CN 102085369 B CN102085369 B CN 102085369B
- Authority
- CN
- China
- Prior art keywords
- gel
- xerostomia
- water
- solution
- chitosan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 208000005946 Xerostomia Diseases 0.000 title claims abstract description 71
- 206010013781 dry mouth Diseases 0.000 title claims abstract description 71
- 238000002360 preparation method Methods 0.000 title abstract description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 33
- 229920001661 Chitosan Polymers 0.000 claims abstract description 27
- 229920003169 water-soluble polymer Polymers 0.000 claims abstract description 21
- 239000000463 material Substances 0.000 claims abstract description 19
- 241000283690 Bos taurus Species 0.000 claims abstract description 16
- 102000016943 Muramidase Human genes 0.000 claims abstract description 16
- 108010014251 Muramidase Proteins 0.000 claims abstract description 16
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 claims abstract description 16
- 229960000274 lysozyme Drugs 0.000 claims abstract description 16
- 235000010335 lysozyme Nutrition 0.000 claims abstract description 16
- 239000004325 lysozyme Substances 0.000 claims abstract description 16
- 210000003022 colostrum Anatomy 0.000 claims abstract description 15
- 235000021277 colostrum Nutrition 0.000 claims abstract description 15
- 230000001954 sterilising effect Effects 0.000 claims abstract description 13
- 108060003951 Immunoglobulin Proteins 0.000 claims abstract description 12
- 102000010445 Lactoferrin Human genes 0.000 claims abstract description 12
- 108010063045 Lactoferrin Proteins 0.000 claims abstract description 12
- 102000018358 immunoglobulin Human genes 0.000 claims abstract description 12
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 claims abstract description 12
- 235000021242 lactoferrin Nutrition 0.000 claims abstract description 12
- 229940078795 lactoferrin Drugs 0.000 claims abstract description 12
- 238000000034 method Methods 0.000 claims abstract description 10
- 230000008569 process Effects 0.000 claims abstract description 8
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 claims abstract description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 54
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 18
- 238000003756 stirring Methods 0.000 claims description 16
- 102000003992 Peroxidases Human genes 0.000 claims description 15
- 108040007629 peroxidase activity proteins Proteins 0.000 claims description 15
- -1 polypropylene Polymers 0.000 claims description 11
- 239000004743 Polypropylene Substances 0.000 claims description 10
- 239000002253 acid Substances 0.000 claims description 10
- 229920001155 polypropylene Polymers 0.000 claims description 10
- 239000011347 resin Substances 0.000 claims description 10
- 229920005989 resin Polymers 0.000 claims description 10
- 239000003795 chemical substances by application Substances 0.000 claims description 8
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical group OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 6
- 210000000481 breast Anatomy 0.000 claims description 6
- 238000012856 packing Methods 0.000 claims description 6
- 229920000193 polymethacrylate Polymers 0.000 claims description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 5
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 claims description 4
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 4
- 239000002131 composite material Substances 0.000 claims description 4
- 230000003647 oxidation Effects 0.000 claims description 4
- 238000007254 oxidation reaction Methods 0.000 claims description 4
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 3
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 3
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 3
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 3
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 3
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 3
- KPQJOKRSYYJJEL-VLQRKCJKSA-K [Na+].[Na+].CC1(C)[C@H](CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@](C)(CC[C@]3(C)CC[C@@]12C)C([O-])=O)O[C@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O)C([O-])=O)C([O-])=O Chemical compound [Na+].[Na+].CC1(C)[C@H](CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@](C)(CC[C@]3(C)CC[C@@]12C)C([O-])=O)O[C@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O)C([O-])=O)C([O-])=O KPQJOKRSYYJJEL-VLQRKCJKSA-K 0.000 claims description 3
- 229940071826 hydroxyethyl cellulose Drugs 0.000 claims description 3
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 3
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 3
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 3
- 229940054190 hydroxypropyl chitosan Drugs 0.000 claims description 3
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 3
- 239000000600 sorbitol Substances 0.000 claims description 3
- 239000000811 xylitol Substances 0.000 claims description 3
- 235000010447 xylitol Nutrition 0.000 claims description 3
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 3
- 229960002675 xylitol Drugs 0.000 claims description 3
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 claims description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 2
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 2
- 235000010358 acesulfame potassium Nutrition 0.000 claims description 2
- 229960004998 acesulfame potassium Drugs 0.000 claims description 2
- 239000000619 acesulfame-K Substances 0.000 claims description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 2
- 150000004702 methyl esters Chemical class 0.000 claims description 2
- 235000013336 milk Nutrition 0.000 claims description 2
- 239000008267 milk Substances 0.000 claims description 2
- 210000004080 milk Anatomy 0.000 claims description 2
- 238000004321 preservation Methods 0.000 claims description 2
- 229940013618 stevioside Drugs 0.000 claims description 2
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims description 2
- 235000019202 steviosides Nutrition 0.000 claims description 2
- 108010011485 Aspartame Proteins 0.000 claims 1
- 239000000605 aspartame Substances 0.000 claims 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims 1
- 235000010357 aspartame Nutrition 0.000 claims 1
- 229960003438 aspartame Drugs 0.000 claims 1
- 210000000214 mouth Anatomy 0.000 abstract description 29
- 208000002064 Dental Plaque Diseases 0.000 abstract description 5
- 208000007027 Oral Candidiasis Diseases 0.000 abstract description 5
- 230000006870 function Effects 0.000 abstract description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 241000894006 Bacteria Species 0.000 abstract description 2
- 208000007117 Oral Ulcer Diseases 0.000 abstract description 2
- 208000002399 aphthous stomatitis Diseases 0.000 abstract description 2
- 238000003912 environmental pollution Methods 0.000 abstract description 2
- 230000035876 healing Effects 0.000 abstract description 2
- 238000011031 large-scale manufacturing process Methods 0.000 abstract description 2
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 108010023244 Lactoperoxidase Proteins 0.000 abstract 1
- 102000045576 Lactoperoxidases Human genes 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 230000000675 anti-caries Effects 0.000 abstract 1
- 235000003599 food sweetener Nutrition 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 229940057428 lactoperoxidase Drugs 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 239000008213 purified water Substances 0.000 abstract 1
- 239000003765 sweetening agent Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 44
- 230000000694 effects Effects 0.000 description 29
- 238000005303 weighing Methods 0.000 description 24
- 206010007134 Candida infections Diseases 0.000 description 8
- 201000003984 candidiasis Diseases 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 210000003296 saliva Anatomy 0.000 description 6
- 206010012601 diabetes mellitus Diseases 0.000 description 5
- 230000005923 long-lasting effect Effects 0.000 description 5
- 210000002200 mouth mucosa Anatomy 0.000 description 5
- GNFTZDOKVXKIBK-UHFFFAOYSA-N 3-(2-methoxyethoxy)benzohydrazide Chemical compound COCCOC1=CC=CC(C(=O)NN)=C1 GNFTZDOKVXKIBK-UHFFFAOYSA-N 0.000 description 4
- 241000222122 Candida albicans Species 0.000 description 4
- 241000287411 Turdidae Species 0.000 description 4
- 238000013019 agitation Methods 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 230000002255 enzymatic effect Effects 0.000 description 4
- 230000035807 sensation Effects 0.000 description 4
- 230000000638 stimulation Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 230000029663 wound healing Effects 0.000 description 4
- 206010039424 Salivary hypersecretion Diseases 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 208000026451 salivation Diseases 0.000 description 3
- 239000001074 1-methoxy-4-[(E)-prop-1-enyl]benzene Substances 0.000 description 2
- 206010006326 Breath odour Diseases 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 2
- 208000032139 Halitosis Diseases 0.000 description 2
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 2
- 102000013275 Somatomedins Human genes 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 208000007287 cheilitis Diseases 0.000 description 2
- 208000002925 dental caries Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 230000009442 healing mechanism Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000008676 import Effects 0.000 description 2
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 2
- 238000001959 radiotherapy Methods 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 2
- QCHFTSOMWOSFHM-WPRPVWTQSA-N (+)-Pilocarpine Chemical compound C1OC(=O)[C@@H](CC)[C@H]1CC1=CN=CN1C QCHFTSOMWOSFHM-WPRPVWTQSA-N 0.000 description 1
- 239000000120 Artificial Saliva Substances 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 102000009660 Cholinergic Receptors Human genes 0.000 description 1
- 108010009685 Cholinergic Receptors Proteins 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 241000371997 Eriocheir sinensis Species 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000002454 Nasopharyngeal Carcinoma Diseases 0.000 description 1
- 206010061306 Nasopharyngeal cancer Diseases 0.000 description 1
- 208000025157 Oral disease Diseases 0.000 description 1
- QCHFTSOMWOSFHM-UHFFFAOYSA-N SJ000285536 Natural products C1OC(=O)C(CC)C1CC1=CN=CN1C QCHFTSOMWOSFHM-UHFFFAOYSA-N 0.000 description 1
- 201000009594 Systemic Scleroderma Diseases 0.000 description 1
- 206010042953 Systemic sclerosis Diseases 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 206010048222 Xerosis Diseases 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 201000003465 angular cheilitis Diseases 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001716 anti-fugal effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000007800 dental corrosion Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 208000024693 gingival disease Diseases 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 208000030194 mouth disease Diseases 0.000 description 1
- 230000003551 muscarinic effect Effects 0.000 description 1
- 201000011216 nasopharynx carcinoma Diseases 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229960001416 pilocarpine Drugs 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 210000003079 salivary gland Anatomy 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
序号 | 理化技术指标 | 单位 | 量值 |
1 | 装量 | g | 30g/瓶 |
2 | 粘度 | Pa.s/m | ≥18 |
3 | pH值 | / | 6.8 |
序号 | 理化技术指标 | 单位 | 量值 |
1 | 装量 | g | 30g/瓶 |
2 | 粘度 | Pa.s/m | ≥20 |
3 | pH值 | / | 6.6 |
序号 | 理化技术指标 | 单位 | 量值 |
1 | 装量 | g | 30g/瓶 |
2 | 粘度 | Pa.s/m | ≥19 |
3 | pH值 | / | 7.0 |
序号 | 理化技术指标 | 单位 | 量值 |
1 | 装量 | g | 30g/瓶 |
2 | 粘度 | Pa.s/m | ≥20 |
3 | pH值 | / | 6.8 |
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011100312546A CN102085369B (zh) | 2011-01-28 | 2011-01-28 | 一种口腔干燥症凝胶医疗用品及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011100312546A CN102085369B (zh) | 2011-01-28 | 2011-01-28 | 一种口腔干燥症凝胶医疗用品及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102085369A CN102085369A (zh) | 2011-06-08 |
CN102085369B true CN102085369B (zh) | 2012-07-04 |
Family
ID=44097530
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2011100312546A Expired - Fee Related CN102085369B (zh) | 2011-01-28 | 2011-01-28 | 一种口腔干燥症凝胶医疗用品及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102085369B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104840958B (zh) * | 2015-05-28 | 2018-03-30 | 广州帝奇医药技术有限公司 | 人工粘膜组合物及其制备方法和应用 |
CN104958778A (zh) * | 2015-06-23 | 2015-10-07 | 青岛博益特生物材料股份有限公司 | 一种口腔抑菌促愈合材料及其应用 |
CN108324681A (zh) * | 2018-03-26 | 2018-07-27 | 南京斯泰尔医药科技有限公司 | 一种治疗口腔念珠菌感染的口腔凝胶剂 |
CN109105708A (zh) * | 2018-05-25 | 2019-01-01 | 徐明灶 | 改善以口腔溃疡为特征上火体质的固体饮料及制备方法 |
GB202007546D0 (en) * | 2020-05-20 | 2020-07-01 | Univ Leeds Innovations Ltd | Formulation |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004011011A1 (en) * | 2002-07-29 | 2004-02-05 | Patrick John Shanahan | Oral and dental composition |
CN101795686A (zh) * | 2007-09-06 | 2010-08-04 | 高露洁-棕榄公司 | 治疗口腔干燥的洁齿剂组合物 |
CN101951877A (zh) * | 2008-02-08 | 2011-01-19 | 高露洁-棕榄公司 | 用于治疗口腔干燥的组合物和方法 |
-
2011
- 2011-01-28 CN CN2011100312546A patent/CN102085369B/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004011011A1 (en) * | 2002-07-29 | 2004-02-05 | Patrick John Shanahan | Oral and dental composition |
CN101795686A (zh) * | 2007-09-06 | 2010-08-04 | 高露洁-棕榄公司 | 治疗口腔干燥的洁齿剂组合物 |
CN101951877A (zh) * | 2008-02-08 | 2011-01-19 | 高露洁-棕榄公司 | 用于治疗口腔干燥的组合物和方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102085369A (zh) | 2011-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102085370B (zh) | 一种口腔炎症性疾病的口腔喷剂及其制备方法 | |
CN103385805B (zh) | 一种益早益晚组合儿童牙膏和一种益晚儿童牙膏 | |
CN110585062B (zh) | 一种透明质酸口腔护理组合物及其制备方法和应用 | |
CN102085369B (zh) | 一种口腔干燥症凝胶医疗用品及其制备方法 | |
CN108939079A (zh) | 一种清热解毒抗菌消炎的口腔保健剂及其制备方法 | |
CN102085371B (zh) | 一种口腔干燥症含漱液医疗用品及其制备方法 | |
CN104257544B (zh) | 一种四联法联动祛口臭组合物牙膏 | |
CN105310960B (zh) | 一种新型多糖抗菌漱口液及其制备方法 | |
CN107811890A (zh) | 一种口腔养护牙膏组合物 | |
CN111920753A (zh) | 一种抗幽门螺杆菌、缓解牙龈炎制剂及其应用 | |
CN106581159B (zh) | 一种儿童口腔护理组合物及一种益早益晚组合儿童牙膏 | |
CN110946778A (zh) | 一种具有消炎抑菌作用的牙膏 | |
CN112426376B (zh) | 一种漱口水及其制备方法 | |
CN111888308B (zh) | 一种预防口腔溃疡和加速口腔粘膜修复的牙膏及工艺 | |
CN101972215A (zh) | 壳寡糖口腔清洁片 | |
CN108498535A (zh) | 一种用于治疗皮肤及黏膜感染的聚维酮碘药物组合物及其制备方法和应用 | |
CN109674875A (zh) | 口腔溃疡护理精华液 | |
CN103432044A (zh) | 一种西瓜霜牙膏及其制备方法 | |
CN101849893A (zh) | 壳寡糖口腔清洁剂 | |
CN105412913A (zh) | 一种鼻腔润湿剂 | |
CN108578342A (zh) | 一种儿童用牙膏 | |
CN106798749A (zh) | 一种聚维酮碘成膜消毒剂及其制备方法和应用 | |
CN112076221B (zh) | 一种脱敏糊剂及其制备方法和用途 | |
CN104906132B (zh) | 一种防治羔羊口炎的膏药制剂 | |
KR20100042364A (ko) | 구강원인구취 및 위장원인구취를 동시에개선하는 조성물방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Oral dry medicine gel medical product and preparation method thereof Effective date of registration: 20211216 Granted publication date: 20120704 Pledgee: Wuhan area branch of Hubei pilot free trade zone of Bank of China Ltd. Pledgor: Wuhan Coupling Medicine Technology Co.,Ltd. Registration number: Y2021420000144 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230403 Granted publication date: 20120704 Pledgee: Wuhan area branch of Hubei pilot free trade zone of Bank of China Ltd. Pledgor: Wuhan Coupling Medicine Technology Co.,Ltd. Registration number: Y2021420000144 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120704 |
|
CF01 | Termination of patent right due to non-payment of annual fee |